Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease
Clin Drug Investig
.
2015 Feb;35(2):149.
doi: 10.1007/s40261-014-0262-6.
Authors
Yalcin Solak
1
,
Seyyid Bilal Acikgoz
,
Mehmet Yildirim
Affiliation
1
Nephrology Division, Sakarya University Research and Training Hospital, Adapazarı, Sakarya, Turkey, yalcinsolakmd@gmail.com.
PMID:
25523130
DOI:
10.1007/s40261-014-0262-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Colchicine / administration & dosage*
Colchicine / pharmacokinetics*
Female
Humans
Kidney / drug effects*
Kidney / metabolism*
Kidney Failure, Chronic / drug therapy*
Kidney Failure, Chronic / metabolism*
Male
Substances
Colchicine